Nutraceutical Therapies in Major Depressive Disorder

Summary

Major depressive disorder (MDD) remains a formidable global health challenge, with standard pharmacological and psychological treatments proving inadequate for a substantial subset of patients. Nutraceuticals—bioactive compounds derived from foods—have gained increasing attention for their potential to modulate neurobiological pathways implicated in depression. These agents encompass vitamins (notably folate and vitamin D), minerals (such as magnesium and zinc), essential fatty acids (particularly omega-3s), amino acids (for example S-adenosylmethionine and N-acetylcysteine) and coenzyme Q10. Mechanistic insights point to effects on one-carbon metabolism, monoamine synthesis, neuroinflammation, oxidative stress and gut–brain axis interactions. In clinical practice, nutraceuticals have been investigated both as monotherapies and as adjuncts to conventional antidepressants, with emerging evidence supporting symptom reduction in selected patient groups. The affordability, favourable safety profiles and global availability of many nutraceuticals render them attractive candidates for integrative treatment strategies. Future directions include refinement of dosing regimens, identification of predictive biomarkers and rigorous long-term safety assessments to optimise individualised care.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Nutraceutical Therapies in Major Depressive Disorder publication trend

The graph below shows the total number of articles in nutraceutical therapies in major depressive disorder across all publications each year (not limited to Nature Index journals).

Technical terms

Nutraceuticals: Bioactive compounds derived from foods that confer health benefits beyond basic nutritional value, often used for disease prevention or therapy.

One-carbon cycle: A network of biochemical reactions involving folate and methyl group transfers essential for DNA synthesis, methylation and neurotransmitter production.

L-methylfolate: The metabolically active form of folate that penetrates the blood–brain barrier to support synthesis of serotonin, dopamine and norepinephrine.

S-Adenosylmethionine (SAMe): A naturally occurring methyl donor involved in the synthesis of monoamine neurotransmitters and epigenetic regulation, with demonstrated antidepressant effects.

Brain-derived neurotrophic factor (BDNF): A neurotrophin critical for neuronal survival, growth and synaptic plasticity, often found at reduced levels in MDD.

References

  1. Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review. Nutrients (2023).
  2. Folate supplementation as a beneficial add‐on treatment in relieving depressive symptoms: A meta‐analysis of meta‐analyses. Food Science & Nutrition (2024).
  3. Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence. Nutrients (2021).
  4. Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. Pharmaceuticals (2021).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.